Navigation Links
Anne Glover and Sir Michael Stratton to meet the press at The EMBO Meeting 2013 in Amsterdam
Date:7/17/2013

HEIDELBERG -- Predisposition to cancer and other diseases, genetic testing, infectious proteins and ubiquitin signalling -- these are some of the topics internationally renowned speakers will tackle at The EMBO Meeting 2013 to be held in Amsterdam, the Netherlands, from 21-24 September 2013.

Sir Michael Stratton, Director of the Wellcome Trust Sanger Institute, Kri Stefnsson, Chief Executive Officer of deCODE Genetics, and Thijn Brummelkamp, Group Leader at the Netherlands Cancer Institute and winner of the 2013 EMBO Gold Medal, will discuss The Future of Cancer Genomics in an exclusive press conference for journalists and science writers from 11-12 am on Monday 23 September.

On the same day, Anne Glover, Chief Scientific Adviser to Jos Manuel Barroso, President of the European Commission, will be talking to journalists in a Meet the Press event at 6.00 pm.

Sessions on epigenetics, vaccines, stem cell signalling and European science policy are also part of the programme for The EMBO Meeting.

The EMBO Meeting first took place in Amsterdam in 2009, when the conference attracted more than 1300 participants from 50 countries. Attendees at this year's meeting will include researchers at all stages of their scientific career. Policy makers, editors, career advisors, journalists, science bloggers and exhibitors from industry will also be attending the conference.

The EMBO Meeting 2013 will offer plenaries and concurrent sessions by first-rate speakers. Media participants will have multiple opportunities to cover news and also gather ideas for future stories:

  • At a keynote lecture at 9:00am on Monday, 23 September, Hans Clevers will discuss the challenges in identifying and targeting tumour stem cells (Lgr5 stem cells in self-renewal and cancer).

  • The Women in Science session features award-winning Australian writer Cordelia Fine, a psychologist with interests in neuroscience and gender. Her latest book, Delusions of gender: The real science behind sex differences, was short-listed for the Victorian Premier's Literary Award for Non-Fiction, the Best Book of Ideas Prize 2011 and the John Llewellyn Rhys Prize 2010.

  • The Special Lecture explores the question Is there life on other planets? Christopher McKay who is Planetary Scientist with the Space Science Division of NASA, will deliver an update about the Mars Curiosity Rover.

  • The role of ubiquitin signalling in cancer is the topic of Vishva Dixit, Vice President of Physiological Chemistry at Genentech, part of the Roche Group, and Adjunct Professor at the University of California, San Francisco.

  • Albert Osterhaus is one of the speakers at the concurrent session on vaccines on Tuesday 24 September from 9-11 am. His team played an important role in the identification of the SARS virus in the Hong Kong outbreak in 2002 and was one of the first to identify human infection with the avian influenza strain H5N1.

  • The full programme is available at http://www.the-embo-meeting.org. Online press registration and more information for journalists is available at: http://www.the-embo-meeting.org/press.html. The Abstract Book will be emailed to registered participants and journalists two weeks before the conference starts. Interview opportunities can be arranged prior to the conference or on site, beginning on Saturday evening after the opening address.


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. Brupbacher Prize goes to cancer researcher Michael Karin
2. Researchers and company from Luxembourg awarded a grant from Michael J. Fox Foundation
3. Michael Barnett of Boston College named Professor of the Year for Massachusetts
4. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
5. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
6. Carnegie Mellon researchers develop artificial cells to study molecular crowding and gene expression
7. Artifact suppression and analysis of brain activities with EEG signals
8. Pressure cooker on steroids treats human waste
9. A calculator to estimate the likelihood of antidepressant response
10. Observing live gene expression in the body
11. Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader ... its elite iris biometric solution on the latest ... LTE at Mobile World Congress 2017 (February ... Booth in Hall 3, Stand 3E10. ... Qualcomm Haven™ security platform—a combination of hardware, ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... , ... February 28, 2017 , ... ... most advanced manufacturing technology for use in filling injectable drug products into vials, ... Vanrx Pharmasystems SA25 robotic work-cell . CEO of Singota Solutions Alisa Wright expressed ...
(Date:2/28/2017)... Feb. 28, 2017  Phosphorus, a computational genomics ... formation of the Phosphorus Scientific Advisory Board, an ... to advise the company on the development of ... initiatives. Please visit http://phosphorus.com/about-us/ to learn ... "We,ve gathered some of the top leaders ...
(Date:2/28/2017)... -- WuXi AppTec, a leading global pharmaceutical, biotechnology ... company, today announced that its Lab Testing Division(LTD),s ... once again passed US FDA,s bioequivalence (BE) inspection ... from FDA thoroughly audited WuXi,s quality system during ... operation infrastructure, equipment, sample storage, archival system, quality ...
(Date:2/28/2017)... CA (PRWEB) , ... February 28, 2017 , ... ACEA ... the treatment of chronic diseases, has announced Dr. Roger (Feng) Luo as the new ... development experience with a number of multinational drug companies, Dr. Luo will now team ...
Breaking Biology Technology: